Reviews Pneumococcal Vaccine Polyvalent


No reviews yet.

Pneumovax Drug Description
PNEUMOVAX® 23
(pneumococcal) Vaccine Polyvalent
DRUG DESCRIPTION



What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)?

Getting pneumococcal disease is much riskier than getting pneumococcal polysaccharide vaccine. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of pneumococcal polysaccharide vaccine causing serious harm, or death, is extremely small.
Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from pneumococcal polysaccharide vaccine...
Read All Potential Side Effects for Pneumovax »




PNEUMOVAX* 23 (Pneumococcal Vaccine Polyvalent) is a sterile, liquid vaccine
for intramuscular or subcutaneous injection. It consists of a mixture of highly
purified capsular polysaccharides from the 23 most prevalent or invasive pneumococcal
types of Streptococcus pneumoniae, including the six serotypes that most
frequently cause invasive drug-resistant pneumococcal infections among children
and adults in the United States.1 (See Table 1.) The 23-valent
vaccine accounts for at least 90% of pneumococcal blood isolates and at least
85% of all pneumococcal isolates from sites which are generally sterile as determined
by ongoing surveillance of U.S. data.2
PNEUMOVAX 23 is manufactured according to methods developed by the Merck Research
Laboratories. Each 0.5 mL dose of vaccine contains 25 µg of each
polysaccharide type in isotonic saline solution containing 0.25% phenol as a
preservative.
Table 1: 23 Pneumococcal Capsular Types Included in PNEUMOVAX
23



Nomenclature
Pneumococcal Types


Danish
1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19F** 19A** 20
22F 23F** 33F


**These serotypes most frequently cause drug-resistant pneumococcal
infections1



REFERENCES
1. Recommendation of the Advisory Committee on Immunization Practices — Prevention
of Pneumococcal Disease, Morbidity and Mortality Weekly Report. 46(RR-8):
1-25, April 4, 1997.
2. Robbins, J.B.; Lee, C.J.; Schiffman, G.; Austrian, R.; Henrichsen, J.; Mäkelä,
P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; Rastogi, S.C.: Considerations
for formulating the second-generation pneumococcal capsular polysaccharide vaccine
with emphasis on the cross-reactive types within groups, J. Infect. Dis. 148:
1136-1159, 1983.
Last reviewed on RxList: 12/18/2008




Pneumovax Drug Description
PNEUMOVAX® 23
(pneumococcal) Vaccine Polyvalent
DRUG DESCRIPTION



What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)?

Getting pneumococcal disease is much riskier than getting pneumococcal polysaccharide vaccine. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of pneumococcal polysaccharide vaccine causing serious harm, or death, is extremely small.
Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from pneumococcal polysaccharide vaccine...
Read All Potential Side Effects for Pneumovax »




PNEUMOVAX* 23 (Pneumococcal Vaccine Polyvalent) is a sterile, liquid vaccine
for intramuscular or subcutaneous injection. It consists of a mixture of highly
purified capsular polysaccharides from the 23 most prevalent or invasive pneumococcal
types of Streptococcus pneumoniae, including the six serotypes that most
frequently cause invasive drug-resistant pneumococcal infections among children
and adults in the United States.1 (See Table 1.) The 23-valent
vaccine accounts for at least 90% of pneumococcal blood isolates and at least
85% of all pneumococcal isolates from sites which are generally sterile as determined
by ongoing surveillance of U.S. data.2
PNEUMOVAX 23 is manufactured according to methods developed by the Merck Research
Laboratories. Each 0.5 mL dose of vaccine contains 25 µg of each
polysaccharide type in isotonic saline solution containing 0.25% phenol as a
preservative.
Table 1: 23 Pneumococcal Capsular Types Included in PNEUMOVAX
23



Nomenclature
Pneumococcal Types


Danish
1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19F** 19A** 20
22F 23F** 33F


**These serotypes most frequently cause drug-resistant pneumococcal
infections1



REFERENCES
1. Recommendation of the Advisory Committee on Immunization Practices — Prevention
of Pneumococcal Disease, Morbidity and Mortality Weekly Report. 46(RR-8):
1-25, April 4, 1997.
2. Robbins, J.B.; Lee, C.J.; Schiffman, G.; Austrian, R.; Henrichsen, J.; Mäkelä,
P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; Rastogi, S.C.: Considerations
for formulating the second-generation pneumococcal capsular polysaccharide vaccine
with emphasis on the cross-reactive types within groups, J. Infect. Dis. 148:
1136-1159, 1983.
Last reviewed on RxList: 12/18/2008




Pneumovax Drug Description
PNEUMOVAX® 23
(pneumococcal) Vaccine Polyvalent
DRUG DESCRIPTION



What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)?

Getting pneumococcal disease is much riskier than getting pneumococcal polysaccharide vaccine. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of pneumococcal polysaccharide vaccine causing serious harm, or death, is extremely small.
Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from pneumococcal polysaccharide vaccine...
Read All Potential Side Effects for Pneumovax »




PNEUMOVAX* 23 (Pneumococcal Vaccine Polyvalent) is a sterile, liquid vaccine
for intramuscular or subcutaneous injection. It consists of a mixture of highly
purified capsular polysaccharides from the 23 most prevalent or invasive pneumococcal
types of Streptococcus pneumoniae, including the six serotypes that most
frequently cause invasive drug-resistant pneumococcal infections among children
and adults in the United States.1 (See Table 1.) The 23-valent
vaccine accounts for at least 90% of pneumococcal blood isolates and at least
85% of all pneumococcal isolates from sites which are generally sterile as determined
by ongoing surveillance of U.S. data.2
PNEUMOVAX 23 is manufactured according to methods developed by the Merck Research
Laboratories. Each 0.5 mL dose of vaccine contains 25 µg of each
polysaccharide type in isotonic saline solution containing 0.25% phenol as a
preservative.
Table 1: 23 Pneumococcal Capsular Types Included in PNEUMOVAX
23



Nomenclature
Pneumococcal Types


Danish
1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19F** 19A** 20
22F 23F** 33F


**These serotypes most frequently cause drug-resistant pneumococcal
infections1



REFERENCES
1. Recommendation of the Advisory Committee on Immunization Practices — Prevention
of Pneumococcal Disease, Morbidity and Mortality Weekly Report. 46(RR-8):
1-25, April 4, 1997.
2. Robbins, J.B.; Lee, C.J.; Schiffman, G.; Austrian, R.; Henrichsen, J.; Mäkelä,
P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; Rastogi, S.C.: Considerations
for formulating the second-generation pneumococcal capsular polysaccharide vaccine
with emphasis on the cross-reactive types within groups, J. Infect. Dis. 148:
1136-1159, 1983.
Last reviewed on RxList: 12/18/2008




Pneumovax Drug Description
PNEUMOVAX® 23
(pneumococcal) Vaccine Polyvalent
DRUG DESCRIPTION



What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)?

Getting pneumococcal disease is much riskier than getting pneumococcal polysaccharide vaccine. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of pneumococcal polysaccharide vaccine causing serious harm, or death, is extremely small.
Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from pneumococcal polysaccharide vaccine...
Read All Potential Side Effects for Pneumovax »




PNEUMOVAX* 23 (Pneumococcal Vaccine Polyvalent) is a sterile, liquid vaccine
for intramuscular or subcutaneous injection. It consists of a mixture of highly
purified capsular polysaccharides from the 23 most prevalent or invasive pneumococcal
types of Streptococcus pneumoniae, including the six serotypes that most
frequently cause invasive drug-resistant pneumococcal infections among children
and adults in the United States.1 (See Table 1.) The 23-valent
vaccine accounts for at least 90% of pneumococcal blood isolates and at least
85% of all pneumococcal isolates from sites which are generally sterile as determined
by ongoing surveillance of U.S. data.2
PNEUMOVAX 23 is manufactured according to methods developed by the Merck Research
Laboratories. Each 0.5 mL dose of vaccine contains 25 µg of each
polysaccharide type in isotonic saline solution containing 0.25% phenol as a
preservative.
Table 1: 23 Pneumococcal Capsular Types Included in PNEUMOVAX
23



Nomenclature
Pneumococcal Types


Danish
1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19F** 19A** 20
22F 23F** 33F


**These serotypes most frequently cause drug-resistant pneumococcal
infections1



REFERENCES
1. Recommendation of the Advisory Committee on Immunization Practices — Prevention
of Pneumococcal Disease, Morbidity and Mortality Weekly Report. 46(RR-8):
1-25, April 4, 1997.
2. Robbins, J.B.; Lee, C.J.; Schiffman, G.; Austrian, R.; Henrichsen, J.; Mäkelä,
P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; Rastogi, S.C.: Considerations
for formulating the second-generation pneumococcal capsular polysaccharide vaccine
with emphasis on the cross-reactive types within groups, J. Infect. Dis. 148:
1136-1159, 1983.
Last reviewed on RxList: 12/18/2008




Pneumovax Drug Description
PNEUMOVAX® 23
(pneumococcal) Vaccine Polyvalent
DRUG DESCRIPTION



What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)?

Getting pneumococcal disease is much riskier than getting pneumococcal polysaccharide vaccine. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of pneumococcal polysaccharide vaccine causing serious harm, or death, is extremely small.
Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from pneumococcal polysaccharide vaccine...
Read All Potential Side Effects for Pneumovax »




PNEUMOVAX* 23 (Pneumococcal Vaccine Polyvalent) is a sterile, liquid vaccine
for intramuscular or subcutaneous injection. It consists of a mixture of highly
purified capsular polysaccharides from the 23 most prevalent or invasive pneumococcal
types of Streptococcus pneumoniae, including the six serotypes that most
frequently cause invasive drug-resistant pneumococcal infections among children
and adults in the United States.1 (See Table 1.) The 23-valent
vaccine accounts for at least 90% of pneumococcal blood isolates and at least
85% of all pneumococcal isolates from sites which are generally sterile as determined
by ongoing surveillance of U.S. data.2
PNEUMOVAX 23 is manufactured according to methods developed by the Merck Research
Laboratories. Each 0.5 mL dose of vaccine contains 25 µg of each
polysaccharide type in isotonic saline solution containing 0.25% phenol as a
preservative.
Table 1: 23 Pneumococcal Capsular Types Included in PNEUMOVAX
23



Nomenclature
Pneumococcal Types


Danish
1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19F** 19A** 20
22F 23F** 33F


**These serotypes most frequently cause drug-resistant pneumococcal
infections1



REFERENCES
1. Recommendation of the Advisory Committee on Immunization Practices — Prevention
of Pneumococcal Disease, Morbidity and Mortality Weekly Report. 46(RR-8):
1-25, April 4, 1997.
2. Robbins, J.B.; Lee, C.J.; Schiffman, G.; Austrian, R.; Henrichsen, J.; Mäkelä,
P.H.; Broome, C.V.; Facklam, R.R.; Tiesjema, R.H.; Rastogi, S.C.: Considerations
for formulating the second-generation pneumococcal capsular polysaccharide vaccine
with emphasis on the cross-reactive types within groups, J. Infect. Dis. 148:
1136-1159, 1983.
Last reviewed on RxList: 12/18/2008





Other reviews about Pneumococcal Vaccine Polyvalent on wordpress

Help needed
  by misformommy
Ananya's doctor was particularly eager that we vaccinate her against Invasive Pneumococcal Diseases (IPD). He gave a small talk on how WHO estimates that a million children die […]


Liste des ingrédients de différents vaccins
  by François M.
Liste des ingrédients de différents vaccinsJe suis tombé sur ceci durant mes lectures de la semaine passée. Il s'agit d'une liste d'ingrédients entrant dans la composition de plusieurs […]


Postsplenectomy Pearls
  by Prem Amalraj
1. Long term antibiotic prophylaxis (Phenoxymethylpenicillin Or erythromycin) 2. Polyvalent Pneumococcal Vaccine ( Pneumovax 23) 0.5ml SC Q 6 years 3. Quadravalent Meningococcal Polysaccharide Vaccine (Menomune) 0.5 ml […]


Was "Pharma Exec" Vaccine Expose' a Hoax?
  by Boulderdash
Source: Vitamin Lawyer Health Freedom Dr. Laibow and I have continued trying to confirm the alleged pharmaceutical company executive who anonymously posted a whistle-blower type expose on the Internet, […]


Vaccines | Aborted Fetal Tissue, Pig Ingredients
  by Joey
Unclean indeed. Vaccines aren't just dangerous, they're unclean: Vaccines Unclean? Rubella and Rabies Grown in Aborted Human Fetal Cells, others grown in Mice, Pig Gelatin, other sources The following is […]


H1N1 Swine Flu Pneumonia, PNEUMOCOCCAL VACCINE MAY NOT BE EFFECTIVE
  by ahrcanum
The CDC is saying that numerous deaths related to the H1N1 Swine Flu are caused by pneumonia. "Schuchat also addressed a CDC study released Wednesday that found that 33 percent […]


Swine Flu Rash, Hives Symptoms
  by ahrcanum
An often unreported symptom of H1N1 Swine Flu is the appearance of hives and a rash.  Children often get rashes as an immune response to many viruses and […]


Ingredients in the Swine Flu H1N1 Vaccine; Resources, Risks and Dangers
  by yellowstaressentials
READ the full published Associated Content Article here A trusted friend of mine who happens to work for a chiropractor sent me an email that disturbed me and piqued […]



Other reviews about Pneumococcal Vaccine Polyvalent on web:

pneumococcal vaccine polyvalent Intramuscular patient information. Detailed drug information for the consumer, includes dosage, pneumococcal vaccine polyvalent Intramuscular ... pneumococcal vaccine polyvalent Intramuscular consumer information ...


Pneumococcal Vaccine, Polyvalent injection To return to the main entry click here . What is pneumococcal vaccine, polyvalent? PNEUMOCOCCAL VACCINE, Pneumococcal Vaccine, Polyvalent injection: Information from ...


Learn about the prescription medication Pneumovax (Pneumococcal Vaccine Polyvalent), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Pneumovax (Pneumococcal Vaccine Polyvalent) Drug Information: Uses ...


Pneumococcal vaccines (i) The currently licensed vaccine. The polyvalent polysaccharide vaccine contains per dose (0.5 ml) 25 micrograms of purified capsular polysaccharide ... Pneumococcal vaccines


All about Pneumococcal Vaccine Polyvalent. View complete and up to date Pneumococcal Vaccine Polyvalent information - part of the Drugs.com trusted medication database. Pneumococcal Vaccine Polyvalent Facts and Comparisons at Drugs.com


PNEUMOCOCCAL VACCINE, POLYVALENT (Pneumovax®, Prevnar™) helps to prevent infection caused by strains of pneumococcus bacteria. These bacteria are a major cause of ear infections ... polyvalent: Definition from Answers.com


Mayo Clinic offers award-winning medical and health information and tools for healthy living. Pneumococcal Vaccine Polyvalent (Intramuscular Route) - MayoClinic.com


Pneumovax II Pneumococcal Vaccine, Polyvalent: Manufacturer: Sanofi Pasteur MSD: Microorganism: Most common types for S. pneumoniae bacteria: Licensed: 01/2006 WAVE - Specific Vaccines Pneumococcal


Uses of This Medicine: Pneumococcal vaccine polyvalent is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to ... Pneumococcal vaccine polyvalent (Intramuscular route)


vaccine. Preparation containing either killed or weakened live microorganisms or their toxins, introduced by mouth, by injection, or by nasal spray to stimulate production of ... pneumococcal vaccine polyvalent definition of pneumococcal vaccine ...





Featured Reviews

Reviews Ritonavir Capsules, Oral Solution

Norvir Drug Description NORVIR (ritonavir) Tablet for Oral Use Co-administration of NORVIR with sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in potentially serious and/or life-threatening adverse events...
Read More  |  Review This
Reviews Eldepryl

Eldepryl Drug Description ELDEPRYL® (selegiline hydrochloride) DRUG DESCRIPTION What are the possible side effects of selegiline (Eldepryl, Zelapar)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Amoxicillin Clavulanate Potassium

Augmentin Chewable Tablets Drug Description AUGMENTIN® (amoxicillin/clavulanate potassium) Powder for Oral Suspension and Chewable Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of...
Read More  |  Review This
Reviews Astra Asigurari

Here are several reasons why not to work with Astra Asigurari. 1. because they do not pay correctly, all large car service shops are not working with them, for example Tiriac Auto. Because of this i had to go with my car to a weird service,...
Read More  |  Review This
Reviews Paliperidone

Invega Drug Description INVEGA®® (paliperidone) Extended-Release Tablets WARNING INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....